Gen X BioSciences

GenX BioSciences is a biotechnology company specializing in the development of exosome-based delivery platforms for precision medicine. The company's core technology, the Exo-V platform, utilizes engineered extracellular vesicles to deliver therapeutic payloads such as siRNA, mRNA, and proteins directly to target cells. By leveraging the natural properties of exosomes, GenX BioSciences aims to overcome traditional drug delivery barriers, particularly in the treatment of cancer and infectious diseases. Their approach focuses on enhancing therapeutic efficacy while reducing off-target toxicity through highly specific cellular targeting. The company is currently in the pre-clinical stage, advancing its pipeline of targeted biologics for solid tumors.